Omaglip Tablet 12.5 mg
Omaglip Tablet 12.5 mg Uses, Dosage, Side Effects, Food Interaction and all others data.
Omaglip Tablet 12.5 mg has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
| Trade Name | Omaglip Tablet 12.5 mg |
| Generic | Omarigliptin |
| Omarigliptin Other Names | Omarigliptin |
| Weight | 12.5 mg |
| Type | Tablet |
| Formula | C17H20F2N4O3S |
| Weight | Average: 398.43 Monoisotopic: 398.12241802 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Navana Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Innovators Monograph
You find simplified version here Omaglip Tablet 12.5 mg
